Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?
Floege
Jürgen
J
D000085:Acetates / Q000008:administration & dosage; D002114:Calcinosis / Q000209:etiology / Q000517:prevention & control*; D002118:Calcium / Q000008:administration & dosage* / Q000097:blood; D002119:Calcium Carbonate / Q000008:administration & dosage; D017610:Calcium Compounds / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D002614:Chelating Agents / Q000008:administration & dosage*; D006801:Humans; D010710:Phosphates / Q000302:isolation & purification*; D011073:Polyamines / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D000069603:Sevelamer
D000085:Acetates; D017610:Calcium Compounds; D002614:Chelating Agents; D010710:Phosphates; D011073:Polyamines; D000069603:Sevelamer; D002119:Calcium Carbonate; D002118:Calcium; C120662:calcium acetate